Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance

被引:25
作者
Lee, Soon Kyu [1 ]
Park, Min-Jung [2 ]
Jhun, Joo Yeon [2 ]
Beak, Jin-Ah [2 ]
Choi, Jeong Won [2 ]
Rye, Jae-Yoon [2 ]
Jang, Jeong Won [1 ]
Bae, Si Hyun [3 ]
Yoon, Seung Kew [1 ]
Choi, Ho Joong [4 ]
You, Young Kyoung [4 ]
Cho, Mi-La [2 ]
Choi, Jong Young [1 ]
机构
[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, Seoul, South Korea
[2] Catholic Univ Korea, Catholic Res Inst Med Sci, Coll Med, Rheumatism Res Ctr, Seoul, South Korea
[3] Catholic Univ Korea, Eunpyeong St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, Seoul, South Korea
[4] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
metformin; tacrolimus; regulatory T cell; Th17; cell; allogeneic response; GVHD; liver transplantation; VERSUS-HOST-DISEASE; LIVER; CYCLOSPORINE; THERAPY; DRUG;
D O I
10.3389/fimmu.2020.581728
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined the effect of combination therapy with metformin and tacrolimus on immune parameters including T regulatory (Treg) and type 17 helper T (Th17) cells in vitro and in vivo in mice and in liver transplantation (LT) patients. T cell proliferation and subtypes after in vitro T cell activation or allogeneic stimulation were evaluated. RNA sequencing and microarray analysis were used to evaluate differences in gene expression. Metformin and tacrolimus were administered to mice with graft-versus-host disease (GVHD) and the effects in vivo were assessed. Five LT patients were treated with metformin and the changes in Treg and Th17 cells examined. Combination therapy decreased Type 1 helper T (Th1) and Th17 cells present after in vitro T cell activation, whereas genes associated with Treg were overexpressed. During in vitro allogeneic stimulation, combination therapy increased Treg cells and decreased T cell proliferation and pro-inflammatory markers. In mice with GVHD, combination treatment decreased the clinical and pathological severity of GVHD. In LT patients, addition of metformin increased the peripheral percentage of CD4+Treg and CD8+Treg cells and decreased CD4+Th17. Our study suggests that the addition of metformin to tacrolimus may improve immunological balance by increasing Treg cells and decreasing Th17 cells.
引用
收藏
页数:11
相关论文
共 20 条
[1]   Differing Effects of Rapamycin or Calcineurin Inhibitor on T-Regulatory Cells in Pediatric Liver and Kidney Transplant Recipients [J].
Akimova, T. ;
Kamath, B. M. ;
Goebel, J. W. ;
Meyers, K. E. C. ;
Rand, E. B. ;
Hawkins, A. ;
Levine, M. H. ;
Bucuvalas, J. C. ;
Hancock, W. W. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (12) :3449-3461
[2]   Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin [J].
Bahrambeigi, Saman ;
Shafiei-Irannejad, Vahid .
BIOCHEMICAL PHARMACOLOGY, 2020, 174
[3]   Drug therapy - Metformin [J].
Bailey, CJ ;
Turner, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579
[4]  
BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110
[5]   Tacrolimus is superior to cyclosporine in liver transplantation [J].
Busuttil, RW ;
Holt, CD .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) :2174-2178
[6]   Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1 [J].
Cha, Jong-Ho ;
Yang, Wen-Hao ;
Xia, Weiya ;
Wei, Yongkun ;
Chan, Li-Chuan ;
Lim, Seung-Oe ;
Li, Chia-Wei ;
Kim, Taewan ;
Chang, Shih-Shin ;
Lee, Heng-Huan ;
Hsu, Jennifer L. ;
Wang, Hung-Ling ;
Kuo, Chu-Wei ;
Chang, Wei-Chao ;
Hadad, Sirwan ;
Purdie, Colin A. ;
McCoy, Aaron M. ;
Cai, Shirong ;
Tu, Yizheng ;
Litton, Jennifer K. ;
Mittendorf, Elizabeth A. ;
Moulder, Stacy L. ;
Symmans, William F. ;
Thompson, Alastair M. ;
Piwnica-Worms, Helen ;
Chen, Chung-Hsuan ;
Khoo, Kay-Hooi ;
Hung, Mien-Chie .
MOLECULAR CELL, 2018, 71 (04) :606-+
[7]   Immune-mediated antitumor effect by type 2 diabetes drug, metformin [J].
Eikawa, Shingo ;
Nishida, Mikako ;
Mizukami, Shusaku ;
Yamazaki, Chihiro ;
Nakayama, Eiichi ;
Udono, Heiichiro .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (06) :1809-1814
[8]   Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells [J].
Fukui, Junichi ;
Inaba, Muneo ;
Ueda, Yusuke ;
Miyake, Takashi ;
Hosaka, Naoki ;
Kwon, A-Hon ;
Sakaguchi, Yutaku ;
Tsuda, Masanobu ;
Omae, Mariko ;
Kamiyama, Yasuo ;
Ikehara, Susumu .
STEM CELLS, 2007, 25 (06) :1595-1601
[9]   Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity [J].
Ghazal, Khaldoun ;
Stenard, Fabien ;
Dahlqvist, Geraldine ;
Barjon, Clement ;
Aoudjehane, Lynda ;
Scatton, Olivier ;
Conti, Filomena .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (03) :237-244
[10]   Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus-based immunosuppression with basiliximab induction [J].
Han, Ji Won ;
Joo, Dong Jin ;
Kim, Jong Hoon ;
Rha, Min-Seok ;
Koh, June Young ;
Park, Hye Jung ;
Lee, Jae Geun ;
Kim, Myoung Soo ;
Kim, Soon Il ;
Shin, Eui-Cheol ;
Park, Jun Yong ;
Park, Su-Hyung .
AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (08) :2058-2069